Search results
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 5 days agoMeanwhile, Moderna is expanding its efforts in cancer treatment. The company is partnered with Merck...
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
Zacks· 17 hours agoSector ETF report for RSPH
Futures: Stocks Extend Gains; Apple Event Next
Investor's Business Daily· 1 day agoKey earnings movers late Monday include Palantir, Axon and Vertex Pharmaceuticals.
Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
Reuters via Yahoo News· 1 day agoWhile the company has not yet applied for approval from the U.S. Food and Drug Administration, a...
Here's Why Merck (MRK) is a Strong Momentum Stock
Zacks· 5 days agoFor new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily ...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 6 days agoThis analysed R&D investments were in the form of strategic acquisitions to expand a company’s prowess in a particular area or by in-licensing drug...
IDEAYA Biosciences Inc (IDYA) Reports Q1 2024 Earnings: Financial and Strategic Developments
GuruFocus.com via Yahoo Finance· 11 hours agoThe company is also preparing for several key milestones in the second half of 2024, including updates on its neoadjuvant uveal melanoma trials and regulatory guidance from the FDA. Financial ...
Cervical Cancer Can Be Eliminated. Alabama Is Leading the Way.
The Wall Street Journal· 2 days agoDoctors are rallying around an audacious goal: eliminating a cancer for the first time. Cervical...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 5 days agoModerna did not record any grant and collaboration revenues during the quarter, compared to $34...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 5 days agoModerna detailed plans for its individual neoantigen cancer vaccine in a first-quarter earnings...
